This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 820
From Proteopedia
(Difference between revisions)
| Line 19: | Line 19: | ||
Each monomer is divided in <scene name='56/568018/Monomer_structure/5'>3 thioredoxin domains (TRX)</scene>: <scene name='56/568018/Monomer_structure/7'>the N-term</scene>, <scene name='56/568018/Monomer_structure/6'>the middle</scene> and the <scene name='56/568018/Monomer_structure/8'>C-term</scene> domains. Each of these has a regular structure: a <scene name='56/568018/Beta_sheet/4'>5 strands beta sheet core</scene> surrounded by <scene name='56/568018/Alpha_helix/3'>4 alpha helices</scene>.<ref name="Martin">PMID:7788290</ref> | Each monomer is divided in <scene name='56/568018/Monomer_structure/5'>3 thioredoxin domains (TRX)</scene>: <scene name='56/568018/Monomer_structure/7'>the N-term</scene>, <scene name='56/568018/Monomer_structure/6'>the middle</scene> and the <scene name='56/568018/Monomer_structure/8'>C-term</scene> domains. Each of these has a regular structure: a <scene name='56/568018/Beta_sheet/4'>5 strands beta sheet core</scene> surrounded by <scene name='56/568018/Alpha_helix/3'>4 alpha helices</scene>.<ref name="Martin">PMID:7788290</ref> | ||
Usually these domains are involved in redox phenomena, which lead to disulfide bounds creation. Here these domains are inactive but play an important role in the polymerization of CASQ2.<ref name="Monomere structure">NCBI Structure Ressource: CASQ2 calsequestrin 2 http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=239372&querygi=429544235&aln=1,227,0,109</ref> | Usually these domains are involved in redox phenomena, which lead to disulfide bounds creation. Here these domains are inactive but play an important role in the polymerization of CASQ2.<ref name="Monomere structure">NCBI Structure Ressource: CASQ2 calsequestrin 2 http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=239372&querygi=429544235&aln=1,227,0,109</ref> | ||
| - | Finally, the C-term Asp-rich extremity is intrisically disordered. | + | Finally, the C-term Asp-rich extremity is intrisically disordered ''(as a consequence, the C-term extrimity cannot be represented in 3D structures)''. |
=== Polymer Structure === | === Polymer Structure === | ||
Within the sarcoplasmic reticulum (SR) lumen, CASQ2 polymerizes to form <scene name='56/568018/Dimer/1'>homodimers</scene>, homotetramers and | Within the sarcoplasmic reticulum (SR) lumen, CASQ2 polymerizes to form <scene name='56/568018/Dimer/1'>homodimers</scene>, homotetramers and | ||
Revision as of 16:05, 3 January 2014
| This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
| |||||||||||
References
- ↑ Cerrone M, Napolitano C, Priori SG. Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation. Heart Rhythm. 2009 Nov;6(11):1652-9. doi: 10.1016/j.hrthm.2009.06.033. Epub 2009 , Jun 30. PMID:19879546 doi:http://dx.doi.org/10.1016/j.hrthm.2009.06.033
- ↑ NCBI Gene Ressource: CASQ2 calsequestrin 2 http://www.ncbi.nlm.nih.gov/gene/845
- ↑ Martin JL. Thioredoxin--a fold for all reasons. Structure. 1995 Mar 15;3(3):245-50. PMID:7788290
- ↑ NCBI Structure Ressource: CASQ2 calsequestrin 2 http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=239372&querygi=429544235&aln=1,227,0,109
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Crystal Structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum (Wang et al., 1998) http://www.nature.com/nsmb/journal/v5/n6/abs/nsb0698-476.html
- ↑ NCBI Structure Ressource: CASQ2 calsequestrin 2 http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi
- ↑ 2+</sup> and interacts with triadin (Shin et al., 2000)">The Asp-rich region at the carboxyl-terminus of calsequestrin binds to Ca2+ and interacts with triadin (Shin et al., 2000) http://www.sciencedirect.com/science/article/pii/S0014579300022468
- ↑ 8.0 8.1 8.2 8.3 8.4 8.5 8.6 8.7 Beard NA, Laver DR, Dulhunty AF. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol. 2004 May;85(1):33-69. PMID:15050380 doi:http://dx.doi.org/10.1016/j.pbiomolbio.2003.07.001
- ↑ 9.0 9.1 9.2 9.3 9.4 9.5 Beard NA, Casarotto MG, Wei L, Varsanyi M, Laver DR, Dulhunty AF. Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation. Biophys J. 2005 May;88(5):3444-54. Epub 2005 Feb 24. PMID:15731387 doi:http://dx.doi.org/10.1529/biophysj.104.051441
Proteopedia page contributors and editors
Marc-Antoine JACQUES and Thomas VUILLEMIN
